AKT1 and neoplasm: As tumor cells frequently acquire defects in autophagy compared with normal cells, pharmacological activation of autophagy through inhibition of Akt/mTOR pathway may kill cancer cells and limit tumorigenesis, especially in cancers with defects in apoptosis.